| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |